Success Metrics

Completion Rate

0%(0/2)

Active Trials

1(33%)

Terminated

2(67%)

Phase Distribution

Ph not_applicable

33%

Ph phase_2

33%

Ph phase_4

33%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Terminated(2)

Detailed Status

Terminated2

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

0.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (33.3%)

Phase 41 (33.3%)

N/A1 (33.3%)

Trials by Status

terminated267%

recruiting133%

Recent Activity

1 active trials

Showing 3 of 3

recruitingphase_4

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease

NCT04522622

terminatednot_applicable

PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot

NCT01322256

terminatedphase_2

Bone Disease in Severely Burned Children

NCT00591162

Clinical Trials (3)

Showing 3 of 3 trials

NCT04522622Phase 4

Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease

Recruiting

NCT01322256Not Applicable

PET/CT Scanning for the Follow-up of Antibiotic Treatment of Infectious Osteoarthritis in the Diabetic Foot

Terminated

NCT00591162Phase 2

Bone Disease in Severely Burned Children

Terminated

All 3 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 3